Xueqiang Peng

Fourth Affiliated Hospital of China Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.9kcitations48works25.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Extracellular vesicles in disease(16), Autophagy in Disease and Therapy(12), Cancer-related molecular mechanisms research(11), MicroRNA in disease regulation(10), RNA modifications and cancer(8)

Publications48 total

Research advances on amino acid starvation interventions for hepatocellular carcinoma
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2025
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
Pharmacological Research·2025· 16 citedOpen Access
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies
Stem Cell Research & Therapy·2024· 40 citedOpen Access
Advancing cancer research through organoid technology
Journal of Translational Medicine·2024· 27 citedOpen Access
STING agonists and PI3Kγ inhibitor co-loaded ferric ion-punicalagin networks for comprehensive cancer therapy
International Journal of Biological Macromolecules·2024· 4 cited
811MO An exploratory study to assess the safety, immunogenicity, and preliminary anti-tumor activity of the EBV mRNA vaccine (WGc-043 injection) in patients with NK/T cell lymphoma
Annals of Oncology·2024Open Access
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Biomarker Research·2024· 23 citedOpen Access
CDKL3 is a targetable regulator of cell cycle progression in cancers
Journal of Clinical Investigation·2024· 7 citedOpen Access
Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer
Cancer Letters·2024· 25 cited
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Acta Pharmaceutica Sinica B·2024· 74 citedOpen Access
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Cell Communication and Signaling·2024· 66 citedOpen Access
Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
Cell Communication and Signaling·2023· 29 citedOpen Access
mRNA vaccine in cancer therapy: Current advance and future outlook
Clinical and Translational Medicine·2023· 118 citedOpen Access
Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
Cell Death and Disease·2023· 35 citedOpen Access
Long non-coding RNA PVT1 induces proliferation, inhibits apoptosis, and induces autophagy by up-regulating Atg5 in rectal cancer cells
World Chinese Journal of Digestology·2023Open Access
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
Cell Death Discovery·2023· 98 citedOpen Access
Retraction Notice to: YAP1 Inhibition in HUVECs Is Associated with Released Exosomes and Increased Hepatocarcinoma Invasion and Metastasis
Molecular Therapy — Nucleic Acids·2022Open Access
Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma
Molecular Immunology·2022· 15 cited
METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma
Human Cell·2022· 26 cited
Mesenchymal/stromal stem cells: necessary factors in tumour progression
Cell Death Discovery·2022· 34 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Hangyu Li(29), Liang Yang(19), Shuo Yang(19), Shibo Wei(18), Jingang Liu(16), Yingbo Ma(14), Qing Fan(13), Hongyuan Jin(12), Mingyao Huang(11), Jiaxing Liu(11), Guangpeng He(11), Xinyu Li(10), Liang Yang(7), Shilei Tang(7), Bo Wu(7), Xinyu Li(6), Hangyu Li(6), Hongyu Zheng(5), Xiaodong Zhang(5), Yan Li(5)